{
    "status": "ok",
    "totalResults": 7,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Publicnow",
            "title": "Vivos Therapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K",
            "description": "(marketscreener.com) \n Item 5.07 Submission of Matters to a Vote of Security Holders.\n \n \n \n On September 22, 2023, Vivos Therapeutics, Inc. conducted its 2023 annual meeting of stockholders . The number of shares of common stock of the Company entitled to vo\u2026",
            "url": "https://www.marketscreener.com/quote/stock/VIVOS-THERAPEUTICS-INC-116418037/news/Vivos-Therapeutics-Submission-of-Matters-to-a-Vote-of-Security-Holders-Form-8-K-44915356/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-25T13:04:02Z",
            "content": "Item 5.07 Submission of Matters to a Vote of Security Holders.\r\nOn September 22, 2023, Vivos Therapeutics, Inc. (the \"Company\") conducted its 2023 annual meeting of stockholders (the \"Annual Meeting\"\u2026 [+2391 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vivos Therapeutics, Inc",
            "title": "Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine",
            "description": "Randomized controlled clinical trial using Vivos\u2019 DNA Oral Appliance Therapy to study the DNA\u2019s impact on OSA versus CPAP Randomized controlled clinical trial using Vivos\u2019 DNA Oral Appliance Therapy to study the DNA\u2019s impact on OSA versus CPAP",
            "url": "https://www.globenewswire.com/news-release/2023/10/11/2758251/0/en/Vivos-Therapeutics-to-Begin-Clinical-Trial-at-Stanford-Medicine.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/22d07f60-2e17-421d-bbc3-748c2402061e",
            "publishedAt": "2023-10-11T11:30:00Z",
            "content": "LITTLETON, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Vivos or the Company\") (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patie\u2026 [+6514 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vivos Therapeutics, Inc",
            "title": "Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion",
            "description": "Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing Company      Subject to Regulatory Approvals, Vivos Could See Revenue...",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755278/0/en/Vivos-Therapeutics-Announces-Strategic-Collaboration-in-the-Middle-East-North-Africa-Region-to-Support-International-Expansion.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/22d07f60-2e17-421d-bbc3-748c2402061e",
            "publishedAt": "2023-10-05T11:30:00Z",
            "content": "Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing Company\r\nSubject to Regulatory Approvals, Vivos Could See Revenue From This Collaboration in 2024\r\nLITTLETON, Colo., O\u2026 [+7097 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vivos Therapeutics, Inc",
            "title": "Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark\u2122 Clear Aligners to Its National Network of Providers",
            "description": "New Relationships Expected to Add Potentially Significant New Revenue Opportunities for Vivos as well as Airway-Focused Expertise and Potential Cost Savings for Vivos-trained Providers New Relationships Expected to Add Potentially Significant New Revenue Oppo\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/04/2754469/0/en/Vivos-Therapeutics-Executes-Strategic-Agreements-with-Ormco-and-On-Demand-Orthodontist-To-Provide-Spark-Clear-Aligners-to-Its-National-Network-of-Providers.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/22d07f60-2e17-421d-bbc3-748c2402061e",
            "publishedAt": "2023-10-04T11:30:00Z",
            "content": "LITTLETON, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the Company or Vivos) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and \u2026 [+8260 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "benzinga.com",
            "title": "Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday\u2019s Mid-Day Session",
            "description": "Gaucho Group Holdings, Inc. VINO jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively. Vivos Therapeutics, Inc. VVOS shares\u2026",
            "url": "https://biztoc.com/x/8a019043209880d5",
            "urlToImage": "https://c.biztoc.com/p/8a019043209880d5/s.webp",
            "publishedAt": "2023-10-04T17:24:09Z",
            "content": "Gaucho Group Holdings, Inc. VINO jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.\u2026 [+303 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Vivos : Quarterly Progress Report - Form 8-K",
            "description": "(marketscreener.com) \n Quarterly Progress Report\n \n \n Intellectual Property\n \n \n Intellectual property remains a priority.\n \n \n Patents\n \n \n \n \n \n \n \u25cf\n \n \n The provisional patent on the chiller and related equipment expires on 12/30/23 so we authorized Indian\u2026",
            "url": "https://www.marketscreener.com/quote/stock/VIVOS-INC-120789858/news/Vivos-Quarterly-Progress-Report-Form-8-K-45038311/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-11T10:37:02Z",
            "content": "Quarterly Progress Report\r\nIntellectual Property\r\nIntellectual property remains a priority.\r\nPatents\r\n<table><tr><td></td><td></td><td>\r\n The provisional patent on the chiller and related equipment e\u2026 [+9075 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vivos Therapeutics, Inc",
            "title": "New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference",
            "description": "Vivos Attracts Wide Group of Experts in Dental and Medical Disciplines With a Shared Vision to Treat the Millions of Patients Suffering with Breathing-Related Sleep Disorders Vivos Attracts Wide Group of Experts in Dental and Medical Disciplines With a Shared\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2752663/0/en/New-York-Times-Best-Selling-Author-James-Nestor-to-Headline-List-of-Speakers-for-Fifth-Annual-Vivos-Breathing-Wellness-Conference.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/22d07f60-2e17-421d-bbc3-748c2402061e",
            "publishedAt": "2023-10-02T11:30:00Z",
            "content": "LITTLETON, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the Company or Vivos) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and \u2026 [+6071 chars]"
        }
    ]
}